Patient P-02285

Synthetic patientMETA-24 · Day 152 · 75+ · F · baseline S14Steering view · 3D Open companion preview

Therapy response

Unstable

Tolerance

Favorable

GI state

Favorable

Inflammatory state

Improving

Nutritional resilience

Favorable

Discontinuation risk

22%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events

solid = observed · dashed = predicted

Day 0 META-24 started — Baseline state S14
Day 18 Trajectory diverged from prediction — Observed response fell below the model's expected path.
Day 108 AD-05 recommended — Adherence Support AD-05
Day 109 Patient accepted — Started AD-05 in the companion
Day 114 No meaningful change — Adherence Support AD-05

What changed?

Trajectory began diverging from predicted response on Day 18.

Primary contributors, last 14 days

Inflammatory activity-5
Treatment adherence-4
GI instability-3

What helped?

Adherence Support AD-05Day 108
Result: no meaningful change

LIFE OS recommendation

No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

Active minutes

Wearable

33 min

stable · +0.5 vs previous 14 d

Sleep duration

Wearable

7.9 h

stable · +0.2 vs previous 14 d

Energy level

Daily log

6.8/10

stable · +0.1 vs previous 14 d

Steps

Wearable

4,585

improving · +277 vs previous 14 d

GI burden

Companion

10.1/100

improving · -8.3 vs previous 14 d

Adherence

Companion

83.8 %

stable · -2.1 vs previous 14 d

Sleep quality

Wearable

63/100

improving · +4.4 vs previous 14 d

Glucose, CGM daily mean

CGM

112 mg/dL

stable · -2.6 vs previous 14 d

This trajectory is doing well — what to keep, what to watch

Steering view →

Heading towards restoration · 80 from the failing basin, 40 from restoration.

Good elements to keep

Butyrate producers intact
hidden · steering +7.5
Protein (supports)
perturbation · steering +3.9
Adherence Support AD-05
intervention · steering +2.9
Protein
supporter · GI -2.7 next day

Main detractors to watch

Rapid metabolizer
hidden · steering -8
Bacteroides fragilis elevated
hidden · steering -7.4
Antibiotic course
perturbation · steering -4.7
Alcohol
perturbation · steering -3.7
Alcohol
detractor · GI +2.9 next day

State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

Alcohol
+2.9detractor · 59%
Protein
-2.7supporter · 95%
Simple carbohydrates
+1.4no signal · 38%
Histamine load
+0.4no signal · 15%
Insoluble fibre
+0.3no signal · 15%
Ultra-processed food
-0.3no signal · 15%
Caffeine
-0.2no signal · 15%
Dietary fat load
+0.1no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure

Butyrate / short-chain fatty acid production ↓25
- MicrobiomeF. prausnitzii depleted
Inflammatory signalling ↓20
- MicrobiomeBacteroides fragilis expansion

DNA

Fictional pharmacogenomic panel

CYP2D6 Rapid metabolizer
Expected exposure

Microbiome

Shannon diversity 3 · butyrate capacity 53/100

Akkermansia muciniphilaNormal
Faecalibacterium prausnitziiLow
Bacteroides fragilisHigh
Bifidobacterium longumLow
EnterobacteriaceaeNormal

Wearable, last 14 days

daily evolution fed into the runtime

HRV: 47 ms
Sleep: 7.3 h
Steps: 5,784
Resting HR: 62 bpm

Daily log: GI score 10, nutritional resilience 68, adherence 84.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview

What to eat

Keep meals regular; three to four moderate portions spaced through the day
Include a cooked vegetable portion with each main meal
Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
Eat slowly and stop at comfortable fullness — smaller volume, more often

What to do

Log the daily check-in; one line is enough
A 15-minute walk after lunch
Keep the sleep window steady
Keep hydration steady: small amounts through the day rather than large volumes at once

What to take

Take the dose at the same time relative to your evening meal
No additional supplements this week
Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

Patient	Similarity	Baseline	Intervention	Outcome	Response today
P-02625	53%	S15	—	—	36
P-02031	49%	S12	AD-05	improved	47
P-02087	49%	S01	BR-03	no change	40
P-02113	48%	S05	—	—	41
P-02093	47%	S05	AD-05	no change	40
P-02522	47%	S01	BR-03	no change	40
P-02343	46%	S03	—	—	34
P-02368	46%	S03	—	—	34
P-02100	45%	S08	—	—	35
P-02161	45%	S13	—	—	28
P-02259	45%	S15	—	—	37
P-02267	45%	S09	BR-03	no change	45